NCT06897384 - High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis | Biotech Hunter

Enrollment

388

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

December 31, 2027

Conditions

Severe Acute Pancreatitis

Interventions

DRUG

Saline (NaCl 0,9 %)

The control group involves only adding 50ml of normal saline to a 50ml syringe, without any labels to ensure identical appearance, and the method of administration and dosage are the same with vitamin C group.

DRUG

Vitamin C (Ascorbic Acid)

Vitamin C at dose of 500mg/kg/24h, 2g/h

Trial Locations (1)

Unknown

Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai

All Listed Sponsors

collaborator

Shanghai Municipal Science and Technology Commission

OTHER_GOV

lead

Ruijin Hospital

OTHER